Insulin Nasal Spray as Treatment for Alzheimer's Dementia
Topic: Aging Related Conditions
Author: Wake Forest Baptist Medical Center - Contact: Marguerite Beck - marbeck@wakehealth.edu
Published: 2015/01/11 - Updated: 2015/01/22
Contents: Summary - Introduction - Main - Related
Synopsis: Insulin delivered by nasal spray may improve memory and mental capabilities in adults with mild cognitive impairment, Alzheimers disease and dementia.
Introduction
The study's subjects were 60 adults diagnosed with amnesic mild cognitive impairment (MCI) or mild to moderate Alzheimer's dementia (AD).
Those who received nasally-administered 40 international unit (IU) doses of insulin detemir, a manufactured form of the hormone, for 21 days showed significant improvement in their short-term ability to retain and process verbal and visual information compared with those who received 20 IU does or a placebo.
Main Digest
Additionally, the recipients of 40 IU doses carrying the APOE-e4 gene - which is known to increase the risk for Alzheimer's - recorded significantly higher memory scores than those who received the loser dosage or placebo, while non-carriers across all three groups posted significantly lower scores.
Previous trials had shown promising effects of nasally-administered insulin for adults with AD and MCI, but this study was the first to use insulin detemir, whose effects are longer-lasting than those of "regular" insulin.
"The study provides preliminary evidence that insulin detemir can provide effective treatment for people diagnosed with mild cognitive impairment and Alzheimer's-related dementia similar to our previous work with regular insulin," said Suzanne Craft, Ph.D., professor of gerontology and geriatric medicine at Wake Forest Baptist and lead author of the study, which is published online in advance of the February issue of the Journal of Alzheimer's Disease.
"We are also especially encouraged that we were able to improve memory for adults with MCI who have the APOE-e4 gene, as these patients are notoriously resistant to other therapies and interventions."
The researchers also sought to determine if the insulin detemir doses would cause any negative side effects, and found only minor adverse reactions among the subjects.
The study's overall results support further investigation of the therapeutic value of insulin detemir as a treatment for Alzheimer's and other neurodegenerative diseases, Craft said.
"Alzheimer's is a devastating illness, for which even small therapeutic gains have the potential to improve quality of life and significantly reduce the overall burden for patients, families and society," she said. "Future studies are warranted to examine the safety and efficacy of this promising treatment."
The research was supported by National Institute of Aging grants P50 AG05136 and T32 AG000258 and the Department of Veteran Affairs.
Co-authors are Laura Baker, Ph.D., Wake Forest Baptist; Amy Claxton, Ph.D., Angela Hanson, M.D., Emily H. Trittschuh, Ph.D., Amy Morgan, R.N., Maureen Callaghan, M.D., and Colin Behl, B.S., Veterans Affairs Puget Sound Health Care System and University of Washington School of Medicine; Brenna Cholerton, Ph.D., University of Washington School of Medicine; and Matthew Arbuckle, Oregon Health Sciences University.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Wake Forest Baptist Medical Center. (2015, January 11 - Last revised: 2015, January 22). Insulin Nasal Spray as Treatment for Alzheimer's Dementia. Disabled World. Retrieved September 10, 2024 from www.disabled-world.com/health/aging/spray.php
Permalink: <a href="https://www.disabled-world.com/health/aging/spray.php">Insulin Nasal Spray as Treatment for Alzheimer's Dementia</a>: Insulin delivered by nasal spray may improve memory and mental capabilities in adults with mild cognitive impairment, Alzheimers disease and dementia.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.